mFluiDX

mFluiDX is a biotech company in Oakland, United States, founded in 2016. It has raised $3.8M across 4 rounds, most recently a $1.5M Grant in June 2019.

Enabling molecular detection anywhere

Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$3.8M
Last Round
$1.5M GrantJun 2019
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 2 investors for this company. The full record is or through the API.

About

mFluiDx is a UC Berkeley spinout developing the SIMPLE CHIP, a low-cost point-of-care molecular diagnostic device that achieves PCR-equivalent sensitivity at the price of rapid antigen tests. The platform uses isothermal amplification and microfluidic technology to simultaneously detect multiple bacterial and viral pathogens from a single cartridge in 7–15 minutes, with fully automated sample-to-answer processing. Founded by Charlie Yeh (UCSF/UC Berkeley Joint PhD), the company is funded by NIH SBIR Phase I and Phase II grants, the Gates Foundation, and received seed funding through the IndieBio accelerator. It was a TechCrunch Battlefield finalist.

Summary

It lists 1–10 employees. It has raised $3.8M in total across 4 rounds, most recently a $1.5M Grant round in Jun 2019. Investors include IndieBio and National Institutes of Health.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase II (NIH)Jun 2019
$1.5M

Sign up to see all 4 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

mFluiDX on Indexed.vc
<a href="https://indexed.vc/companies/mfluidx"><img src="https://indexed.vc/api/badge/company/mfluidx" alt="mFluiDX on Indexed.vc" width="260" height="76" /></a>